Lung surfactant and reactive oxygen-nitrogen species: Antimicrobial activity and host-pathogen interactions

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 3 25-3, 2001, Pages

  Hickman Davis, Judy M ^a   Fang, Ferric C ^b   Nathan, Carl ^c   Shepherd, Virginia L ^d   Voelker, Dennis R ^e   Wright, Jo Rae ^f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collectins; Innate immunity; Macrophages; Nitric oxide; Peroxynitrite; Signal transduction; Surfactant protein A

Indexed keywords

COLLECTIN; LUNG SURFACTANT; MANNOSE; N ACETYLGLUCOSAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANTIGEN RECOGNITION; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; FUNGICIDAL ACTIVITY; HOST PARASITE INTERACTION; HUMAN; IMMUNITY; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 0034832902     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.3.l517     Document Type: Conference Paper

References (54)

1. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
2. Nitric oxide production by rat alveolar macrophages can he modulated in vitro by surfactant protein A
3. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo
4. The comparative toxicity of nitric oxide and peroxymitrite to Escherichia coli
5. Peroxynitrite reductase activity of bacterial peroxiredoxins
6. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates
7. Purification of a cell-surface receptor for surfactant protein A
8. Collectins and pulmonary innate immunity
9. Collectins and pulmonary host defense
10. Genetic and fedex determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model
11. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi
12. Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-gamma
13. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity
14. Modulation of the alveolar macrophage superoxide production by protein phosphorylation
15. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human maerophages
16. Collectin structure: A review
17. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite
18. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages
19. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: An interspecies comparison
20. Modulation of nitric oxide production by lung surfactant in alveolar macrophages
21. Surfactant protein A regulates cytokine production in the monocytic cell line THP- 1
22. Inducible nitric oxide synthase in human diseases
23. Pulmonary surfactant proteins
24. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
25. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
26. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection
27. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung
28. Surfactant protein A and surfactant protein D in health and disease
29. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vive
30. Surfactant protein A amino acids Glu195 and Arg197 are essential for receptor binding, phospholipid aggregation, regulation of secretion, and the facilitated uptake of phospholipid by type II cells
31. The Cys6 intermolecular disulfide bond and the collagen-like region of rat SP-A play critical roles in interactions with alveolar type II cells and surfactant lipids
32. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages
33. Inducible nitric oxide synthase: What difference does it make?
34. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
35. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages
36. Chimeras of surfactant proteins A and D identify the carbohydrate recognition domains as essential for phospholipid interaction
37. Altered carbohydrate recognition specificity engineered into surfactant protein D reveals different binding mechanisms for phosphatidylinositol and glucosylceramide
38. The role of the amino-terminal domain and the collagenous region in the structure and the function of rat surfactant protein D
39. Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages
40. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages
41. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis
42. Mutational analysis of Arg197 of rat surfactant protein A. His197 creates specific lipid uptake defects
43. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes
44. Surfactant proteins A and D bind CD14 by different mechanisms
45. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14
46. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase
47. Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages
48. Nitric oxide production by human alveolar macrophages in pulmonary disease
49. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages
50. Oxygen-dependent anti-Salmonella activity of macrophages
51. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro
52. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor
53. Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway
54. Immunomodulatory functions of surfactant